First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Pfizer
Lomond Therapeutics Holdings, Inc.
Celgene
Ipsen
Hutchmed
Hutchmed
Pfizer
Bayer
Jonsson Comprehensive Cancer Center
Takeda
Fred Hutchinson Cancer Center